t: slim x2 insulin delivery system (Tandem Diabetes)
90
Structured Review
Tandem Diabetes
t: slim x2 insulin delivery system
T: Slim X2 Insulin Delivery System, supplied by Tandem Diabetes, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t%3A+slim+x2+insulin+delivery+system/t+slim+insulin+pump/pmc12035310-21-86-91
Average 90 stars, based on 1 article reviews
T: Slim X2 Insulin Delivery System, supplied by Tandem Diabetes, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t%3A+slim+x2+insulin+delivery+system/t+slim+insulin+pump/pmc12035310-21-86-91
Average 90 stars, based on 1 article reviews
t: slim x2 insulin delivery system - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Insulin Pump Alarms During Adverse Events: A Qualitative Descriptive Study. Article Snippet: Objective: Explore alarm signals cited in insulin pump-associated adverse events (AEs), describe the clinical consequences and other root cause informing remarks that cooccurred with the alarm signals, and identify opportunities for improvements to patient education, instructional materials, and alarm systems to prevent future AEs.. Research Design and Methods: We explored the type, frequency, and associated clinical consequences of alarm signals cited in a pre-coded data set of 2294 insulin pump-associated AEs involving the MiniMed 670G, MiniMed 630G, and t:slim X2.. We also explored the clinical consequences and other root cause informing remarks that cooccurred with the top 10 most frequently cited alarm signals. Article Title: Severe Insulin Pump-Related Adverse Events: Potential Root Causes and Impact of the COVID-19 Pandemic. Article Snippet: Objective: To explore insulin pump-associated severe adverse events (SAEs) involving intensive care unit (ICU) admissions and deaths and examine the impact of the COVID-19 pandemic on these SAEs.. Methods: Qualitative template analysis of narrative data in reported insulin pump-associated SAEs occurring between May 1, 2019, and January 31, 2021, involving MiniMed 670G, MiniMed 630G, Omnipod, Omnipod DASH, and t:slim X2 insulin pumps.. Results: Over the 21-month measurement period, 460 SAEs involving an ICU admission and 288 SAEs involving a death were reported to the Food and Drug Administration. Article Title: Comparison of Computational Statistical Packages for the Analysis of Continuous Glucose Monitoring Data with a Reference Software, "Ambulatory Glucose Profile," in Type 1 Diabetes. Article Snippet: Objective: To compare the accuracy of commonly used continuous glucose monitoring (CGM) analysis programs with ambulatory glucose profile (AGP) and Dexcom Clarity (DC) in analyzing CGM metrics in patients with type 1 diabetes (T1D).. Research Methods: CGM data up to 90 days from 152 adults using the same CGM and automated insulin delivery system with T1D were collected.. Six of the 19 CGM analysis programs (CDGA, cgmanalysis, Glyculator, iglu, EasyGV, and GLU) were selected to compare with AGP and DC. Article Title: Insulin Pump Alarms During Adverse Events: A Qualitative Descriptive Study Article Snippet: This data set included insulin pump-associated AE narratives extracted from the Food and Drug Administration (FDA) Manufacturer and User Facility Device Experience (MAUDE) database that: (1) occurred between January 1 and June 30, 2020, (2) were classified as an injury or death, and (3) involved five insulin pump models marketed in the United States at that time: the MiniMed 670G Insulin Pump and MiniMed 630G Insulin Pump (Medtronic, Minneapolis, Minnesota), Omnipod Insulin Management System and Omnipod DASH Insulin Management System (Insulet Corp., Action Massachusetts), and t: |